僑銀股份(002973.SZ):收到總額不超6.08億元遵義綏陽城鄉環衞一體化項目特許經營權中標通知書
格隆匯1月6日丨僑銀股份(002973.SZ)公佈,公司於2021年12月31日披露了《關於預中標總金額不超過6.08億元貴州省遵義市綏陽縣城鄉環衞一體化項目特許經營權的提示性公吿》(公吿編號:2021-143)。近日,公司已收到綏陽縣城鄉環衞一體化項目特許經營權的《中標通知書》。
中標金額:2635萬元/年;特許經營權:20年;預估中標總金額:根據調價原則,每3年由合同雙方共同協商增長一次相應單價,增加幅度每次控制在5%以內,中標總金額將不超過6.08億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.